Nathalie Coutinet, health economist, estimates on franceinfo that this choice of subsidy by the State is “not at all justified” and “absolutely not judicious” given the condemnation of the Servier laboratories in the Mediator affair.
Article written by
Posted
Reading time : 1 min.
The payment by the State of a subsidy of 800,000 euros to Servier laboratories as part of the drug reindustrialization plan is a decision “incomprehensible”estimated Friday March 25 on franceinfo Nathalie Coutinet, health economist, teacher-researcher at the Sorbonne Paris Nord University. “Obviously, it seems necessary to relocate some of the pharmaceutical products to French, or even European, territory, but it may not be the right laboratory and the right drugs”points out Nathalie Coutinet.
The economist criticizes a choice of subsidy “not at all justified” and “absolutely not wise”considering “because the Servier laboratory was condemned for deception”. It also emphasizes that the medicinal products concerned “do not present a major therapeutic interest, these are drugs that are deemed so useless that they are not reimbursed by Social Security.” Indeed, some of the drugs produced in the factory concerned, that of Gidy (Loiret) are deemed useless or even dangerous by the health authorities, as revealed this week The chained Duck.
“Perhaps a little more time is needed to better target the molecules that should be manufactured in the territory.“, comments Nathalie Coutinet, also co-author with Philippe Abécassis of Drug economy published in 2018 by Editions de la Découverte. “If we have to relocate molecules, it is obviously the major therapeutic drugs that are most frequently in short supply.argues the teacher-researcher. It is often anti-cancer, sometimes also vaccines which have interests in the case of certain cancers.